Post‐trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury
Open Access
- 4 January 2007
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 101 (1), 182-200
- https://doi.org/10.1111/j.1471-4159.2006.04354.x
Abstract
We have previously reported neuroprotection in spinal cord injury (SCI) by Lipitor [atorvastatin (AT)]-pre-treatment. Though informative, pre-treatment studies find only limited clinical application as trauma occurrence is unpredictable. Therefore, this study investigates the efficacy of AT treatment post-SCI. In a rat model of contusion-SCI resulting in complete hindlimb paralysis, AT treatment (5 mg/kg; gavage) was begun 2, 4, or 6 h post-SCI followed by a once daily dose thereafter for 6 weeks. While the placebo vehicle (VHC)-SCI rats showed substantial functional deficit, AT-SCI animals exhibited significant functional recovery. AT diminished injury-induced blood–spinal cord barrier (BSCB) dysfunction with significantly reduced infiltration and tumor necrosis factor-α/interleukin-1β/inducible nitric oxide synthase expression at site of injury. BSCB protection in AT-SCI was attributable to attenuated matrix metalloproteinase-9 (MMP9) expression – a central player in BSCB disruption. Furthermore, endothelial MMP9 expression was found to be RhoA/ROCK pathway-mediated and regulated by AT through an isoprenoid-dependent mechanism. Attenuation of these early inflammatory events reduced secondary damage. Significant reduction in axonal degeneration, myelin degradation, gliosis, and neuronal apoptosis with resultant enhancement in tissue sparing was observed in AT-SCI compared with VHC-SCI. In summary, this novel report presenting the efficacy of post-injury AT treatment might be of critical therapeutic value as effective treatments are currently unavailable for SCI.Keywords
This publication has 73 references indexed in Scilit:
- Statins as antiinflammatory and immunomodulatory agents: A future in rheumatologic therapy?Arthritis & Rheumatism, 2006
- Consequences of noggin expression by neural stem, glial, and neuronal precursor cells engrafted into the injured spinal cordExperimental Neurology, 2005
- HMG-CoA Reductase Inhibitors Improve Acute Ischemic Stroke OutcomeStroke, 2005
- Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in ratsJournal of Neuroscience Research, 2004
- The effects of magnesium sulfate on blood-brain barrier disruption caused by intracarotid injection of hyperosmolar mannitol in ratsLife Sciences, 2004
- Inflammation, degeneration and regeneration in the injured spinal cord: insights from DNA microarraysTrends in Neurosciences, 2003
- Do Statins Afford Neuroprotection in Patients with Cerebral Ischaemia and Stroke?CNS Drugs, 2001
- MASCIS Evaluation of Open Field Locomotor Scores: Effects of Experience and Teamwork on ReliabilityJournal of Neurotrauma, 1996
- Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic windowBrain Research, 1995
- β-Amyloid precursor protein (βAPP) as a marker for axonal injury after head injuryNeuroscience Letters, 1993